NCT05084846 (FluHeart) is a clinical trial in Influenza, sponsored by University Hospital, Gentofte, Copenhagen.

Who is sponsoring NCT05084846?

NCT05084846 is sponsored by University Hospital, Gentofte, Copenhagen.

What condition does NCT05084846 study?

NCT05084846 studies Influenza, Cardiovascular Complication.

Is NCT05084846 still recruiting?

NCT05084846 is currently status unknown. Last updated 26 June 2023.

Last reviewed 2023-06-26 · How we verify

NCT05084846: FluHeart

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection

Status unknown Last updated 26 June 2023

What this trial tests

trial in Influenza in 300 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
1 April 2024

31 March 2025

Quick facts

Lead sponsor	University Hospital, Gentofte, Copenhagen
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 January 2022
Primary completion	1 April 2024
Estimated completion	31 March 2025
Sites	2 locations across Denmark

Conditions studied

Influenza — all drugs for Influenza →
Cardiovascular Complication — all drugs for Cardiovascular Complication →

Sponsor

University Hospital, Gentofte, Copenhagen

Who can join

18 and older, any sex, with Influenza or Cardiovascular Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

"Influenza and the Heart: An investigation into the acute and lasting cardiac effects of influenza infection" the investigators aim to assess the mechanisms for cardiovascular disease in patients suffering an acute influenza infection. The project will be carried out by creating a prospective clinical cohort study of consecutive patients hospitalized at Herlev \& Gentofte University Hospital with a laboratory confirmed influenza.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study.
Skaarup KG, Davidovski FS, Durukan E, Modin D, et al · · 2025 · cited 5× · PMID 39965617 · DOI 10.1111/irv.70067
Inflammation and Cardiac Dysfunction in Hospitalized Patients With Influenza: The FluHeart Study.
Skaarup KG, Davidovski FS, Durukan E, Rastoder E, et al · · 2026 · PMID 42152788 · DOI 10.1111/irv.70266

Verify or expand the search:

Other recruiting trials for Influenza

Currently open trials in the same condition.

NCT07215858 — BPL-1357 Against H1N1 Influenza Virus Challenge · Phase 2 · recruiting
NCT07496450 — A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · recruiting
NCT07302256 — A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above · Phase 1 · recruiting
NCT07431840 — Immune Defense Protein Impact On Respiratory Immune Outcomes · NA · recruiting
NCT07485855 — Influenza Vaccination Strategy for Patients With Hematologic Malignancy · Phase 3 · recruiting

Other University Hospital, Gentofte, Copenhagen trials

Trials by the same sponsor.

NCT07171723 — Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment · Phase 1, PHASE2 · recruiting
NCT06934473 — Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals · NA · recruiting
NCT06845033 — Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity · NA · not yet recruiting
NCT06787001 — Understanding How Gut and Brain Barriers Are Linked to Inflammation in Obesity · completed
NCT06881459 — The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05084846 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Gentofte, Copenhagen
Last refreshed: 26 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05084846.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing